Filing Details

Accession Number:
0001127602-21-004193
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-05 16:46:30
Reporting Period:
2021-02-04
Accepted Time:
2021-02-05 16:46:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
313143 Haemonetics Corp HAE Surgical & Medical Instruments & Apparatus (3841) 042882273
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1400563 J Charles Dockendorff 125 Summer Street
Boston MA 02110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-04 12,180 $35.50 25,935 No 4 M Direct
Common Stock Disposition 2021-02-04 12,180 $134.53 13,755 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-02-04 12,180 $0.00 12,180 $35.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-07-23 2021-07-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,568 Indirect By GRAT
Footnotes
  1. The reporting person exercised options that were granted in 2014 and scheduled to expire on July 23, 2021, as reflected in this Form 4.
  2. This number includes unvested restricted stock units previously reported.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.14 to $135.00, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Reflects shares held by a grantor retained annuity trust, of which Mr. Dockendorff is the sole trustee, subsequent to an exempt transfer by Mr. Dockendorff.
  5. Options vest 100% on the first anniversary of the date of grant.